Xu B - Search Results

1

Ribociclib plus Endocrine Therapy in Early Breast Cancer.

Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, Fasching PA, Crown J, Bardia A, Chia S, Im SA, Ruiz-Borrego M, Loi S, Xu B, Hurvitz S, Barrios C, Untch M, Moroose R, Visco F, Afenjar K, Fresco R, Severin I, Ji Y, Ghaznawi F, Li Z, Zarate JP, Chakravartty A, Taran T, Hortobagyi G. Slamon D, et al. Among authors: xu b. N Engl J Med. 2024 Mar 21;390(12):1080-1091. doi: 10.1056/NEJMoa2305488. N Engl J Med. 2024. PMID: 38507751 Clinical Trial.

2

[Results of combined therapy for 1260 patients with small cell lung cancer].

Chen D, Zhang X, Yin W, Sun Y, Miao Y, Feng F, Wang J, Wang M, Zhang H, Feng Q, Xu B, Shi Y. Chen D, et al. Among authors: xu b. Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):602-4. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12667336 Chinese.

3

[Serum her-2/neu level and related factors in patients with breast cancer].

Yuan P, Xu BH, Zhang C, Qi J. Yuan P, et al. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):573-4. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690565 Chinese.

4

[Clinical characteristics and prognosis of breast cancer patients with vascular invasion].

Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y. Zhao WH, et al. Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):137-40. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17645853 Chinese.

5

Paclitaxel plus carboplatin for women with advanced breast cancer.

Liu J, Li Q, Zhang P, Wang JY, Zhao LM, Xu BH. Liu J, et al. Chin Med Sci J. 2007 Jun;22(2):93-7. Chin Med Sci J. 2007. PMID: 17763580

6

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Pivot XB, Klimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat LT, Roché HH. Thomas ES, et al. Among authors: xu b. J Clin Oncol. 2007 Nov 20;25(33):5210-7. doi: 10.1200/JCO.2007.12.6557. Epub 2007 Oct 29. J Clin Oncol. 2007. PMID: 17968020 Clinical Trial.

7

[Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].

Guan Y, Xu BH. Guan Y, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):196-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756935 Chinese.

8

[Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].

Fan Y, Guan Y, Zhao WH, Li Q, Xu BH. Fan Y, et al. Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):917-20. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173993 Chinese.

9

[Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer].

Yao SY, Xu BH, Li Q, Zhang P, Wang JY, Yuan P, Ma F, Cai RG. Yao SY, et al. Zhonghua Yi Xue Za Zhi. 2010 Mar 2;90(8):526-8. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20367963 Chinese.

10

[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].

Zhang P, Xu BH, Ma F, Li Q. Zhang P, et al. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):128-31. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403244 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,584 results

Search Page